Strong Q3 results, 4:1 bonus issue approved

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

CUPID · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.5%Reaction day

₹78.05

prior close

₹81.20

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.8%+0.7% vs market

Personal Care peers, median of 13sector+1.5%+1.0% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.0 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.2

10m

+1.9

15m

+2.1

30m

+7.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.5+1.8+0.7+1.5+1.0

Next day

+5.6+0.5+5.0+2.4+3.2

+6.5+4.3+2.3+3.5+3.0

+9.7+5.6+4.0+3.9+5.8

+8.1+4.6+3.5+4.6+3.6

+8.3+3.8+4.6+5.1+3.2

+11.4+7.5+3.9+5.3+6.1

15d

+7.6+3.8+3.8+3.0+4.6

-1.6-0.3-1.3-0.6-1.0

+6.3-9.6+15.9-15.0+21.3

+53.7+9.9+43.8-3.5+57.3

UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cupid Limited Q3 FY26 revenue from operations nearly doubled year on year to Rs 93.51 crore; net profit surged to Rs 32.87 crore versus Rs 11.08 crore. Nine month revenue rose to Rs 237.75 crore and PAT to Rs 72 crore. Board approved a 4:1 bonus share issue and increased authorized capital from Rs 50 crore to Rs 150 crore, subject to shareholder and regulatory approvals. Statutory auditors gave an unqualified opinion.

Likely market impact

Strong earnings likely positive. Bonus will quintuple share count, lifting liquidity but mechanically diluting EPS. Awaiting shareholder approval.